Rubén Martín‐Escolano

Preclinical studies of toxicity and safety of the AS-48 bacteriocin

Rubén Cebrián, Maria Elena Rodríguez‐Cabezas, Rubén Martín‐Escolano et al. · Journal of Advanced Research · 2019 · 64 citations · Full text

Life Sciences, Microbiology, Toxicology +15

Second Generation of Mannich Base-Type Derivatives with <i>in Vivo</i> Activity against <i>Trypanosoma cruzi</i>

Rubén Martín‐Escolano, Elsa Moreno‐Viguri, Mery Santivañez‐Veliz et al. · Journal of Medicinal Chemistry · 2018 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

In Vitro and in Vivo Anti-<i>Trypanosoma cruzi</i> Activity of New Arylamine Mannich Base-Type Derivatives

Elsa Moreno‐Viguri, Carmen Jiménez-Montes, Rubén Martín‐Escolano et al. · Journal of Medicinal Chemistry · 2016 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Library of Seleno-Compounds as Novel Agents against Leishmania Species

Álvaro Martín‐Montes, Daniel Plano, Rubén Martín‐Escolano et al. · Antimicrobial Agents and Chemotherapy · 2017 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Insights into Chagas treatment based on the potential of bacteriocin AS-48

Rubén Martín‐Escolano, Rubén Cebrián, Javier Martín‐Escolano et al. · International Journal for Parasitology Drugs and Drug Resistance · 2019 · 28 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17